A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients

被引：0

作者：

M Gentile

T D Shanafelt

G Cutrona

S Molica

G Tripepi

I Alvarez

F R Mauro

N Di Renzo

F Di Raimondo

I Vincelli

K Todoerti

S Matis

C Musolino

S Fabris

E Vigna

L Levato

S Zupo

F Angrilli

U Consoli

G Festini

G Longo

A Cortelezzi

A Arcari

M Federico

D Mannina

A G Recchia

A Neri

N E Kay

M Ferrarini

F Morabito

机构：

[1] Hematology Unit,Department of Onco

[2] A.O. of Cosenza,hematology

[3] Mayo Clinic,Division of Hematology, Department of Internal Medicine

[4] SS Molecular Diagnostics IRCCS S. Martino-IST,Dipartimento di diagnostica della patologia e delle cure ad alta complessità tecnologica

[5] Pugliese-Ciaccio Hospital,Department of Oncology and Haematology

[6] Consiglio Nazionale delle Ricerche,Division of Haematology, Dipartimento Oncologico e Tecnologie Avanzate

[7] Istituto di Fisiologia Clinica,Divisione di Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia

[8] Arcispedale S. Maria Nuova/IRCCS,Division of Haematology, Department of Biomedical Sciences

[9] Università La Sapienza,Dipartimento di Onco

[10] Hematology Unit,Ematologia

[11] Ospedale Vito Fazzi,Department of Clinical Sciences and Community Health

[12] University of Catania and Ferrarotto Hospital,Department of Hematology

[13] Hematology Unit,Dipartimento ad Attività Integrata Oncologia

[14] A.O. of Reggio Calabria,Dipartimento di Oncologia

[15] Reggio Calabria,Dipartimento di Oncologia ed Ematologia, Department of Onco

[16] Laboratory of Preclinical and Translational Research,Hematology

[17] IRCCS,Department of Onco

[18] Referral Cancer Center of Basilicata,hematology

[19] Direzione Scientifica IRCCS,Divisione di Ematologia

[20] San Martino IST,undefined

[21] Division of Haematology,undefined

[22] Dipartimento di Medicina Interna,undefined

[23] University of Messina,undefined

[24] University of Milano and Hematology CTMO,undefined

[25] Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico,undefined

[26] Ospedale Santo Spirito,undefined

[27] U.O.S. di Emato-Oncologia,undefined

[28] Ospedale Garibaldi-Nesima,undefined

[29] Centro di Riferimento Ematologico-Seconda Medicina,undefined

[30] Azienda Ospedaliero-Universitaria,undefined

[31] Ospedali Riuniti,undefined

[32] Unità di Ematologia,undefined

[33] Ospedale San Vincenzo,undefined

[34] Hematology Unit,undefined

[35] Guglielmo da Saliceto Hospital,undefined

[36] Università di Modena Centro Oncologico Modenese,undefined

[37] Ospedale Papardo,undefined

[38] Biotechnology Research Unit,undefined

[39] Azienda Sanitaria Provinciale di Cosenza,undefined

来源：

Leukemia | 2016年 / 30卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1440 / 1443

页数：3

共 50 条

[1] A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients
Gentile, M.
Shanafelt, T. D.
Cutrona, G.
Molica, S.
Tripepi, G.
Alvarez, I.
Mauro, F. R.
Di Renzo, N.
Di Raimondo, F.
Vincelli, I.
Todoerti, K.
Matis, S.
Musolino, C.
Fabris, S.
Vigna, E.
Levato, L.
Zupo, S.
Angrilli, F.
Consoli, U.
Festini, G.
Longo, G.
Cortelezzi, A.
Arcari, A.
Federico, M.
Mannina, D.
Recchia, A. G.
Neri, A.
Kay, N. E.
Ferrarini, M.
Morabito, F.
[J]. LEUKEMIA, 2016, 30 (06) : 1440 - 1443
[2] A Comprehensive Progression Risk Score to Predict Treatment Free Survival for Early Stage Chronic Lymphocytic Leukemia Patients
Gentile, Massimo
Shanafelt, Tait D.
Cutrona, Giovanna
Molica, Stefano
Tripepi, Giovanni
Alvarez, Isabel
Romana Mauro, Francesca
Di Renzo, Nicola
Di Raimondo, Francesco
Vincelli, Iolanda D.
Todoerti, Katia
Matis, Serena
Musolino, Caterina
Fabris, Sonia
Vigna, Ernesto
Levato, Luciano
Zupo, Simona
Angrilli, Francesco
Consoli, Ugo
Festini, Gianluca
Longo, Giuseppe
Cortelezzi, Agostino
Arcari, Annalisa
Federico, Massimo
Mannina, Donato
Grazia Recchia, Anna
Kay, Neil E.
Ferrarini, Manlio
Neri, Antonino
Morabito, Fortunato
[J]. BLOOD, 2015, 126 (23)
[3] Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Winkelmann, Nils
Rose-Zerilli, Matthew
Forster, Jade
Parry, Marina
Parker, Anton
Gardiner, Anne
Davies, Zadie
Steele, Andrew J.
Parker, Helen
Cross, Nicholas C. P.
Oscier, David G.
Strefford, Jonathan C.
[J]. HAEMATOLOGICA, 2015, 100 (06) : E237 - E239
[4] A GLOBAL PROGRESSION RISK SCORE FOR EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: THE NEVER-ENDING STORY
Gentile, M.
Shanafelt, T. D.
Cutrona, G.
Molica, S.
Tripepi, G.
Ilariucci, F.
Mauro, F. R.
Di Renzo, N.
Di Raimondo, F.
Vincelli, I.
Todoerti, K.
Matis, S.
Musolino, C.
Maura, F.
Fabris, S.
Lionetti, M.
Levato, L.
Zupo, S.
Angrilli, F.
Consoli, U.
Festini, G.
Longo, G.
Cortelezzi, A.
Musto, P.
Federico, M.
Mannina, D.
Neri, A.
Kay, N. E.
Ferrarini, M.
Morabito, F.
[J]. HAEMATOLOGICA, 2015, 100 : 77 - 77
[5] A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression
Condoluci, Adalgisa
di Bergamo, Lodovico Terzi
De Paoli, Lorenzo
Delgado, Julio
Gentile, Massimo
Doubek, Michael
Mauro, Francesca Romana
Mattsson, Mattias
Cutrona, Giovanna
Kotaskova, Jana
Deambrogi, Clara
Gerber, Bernhard
Spina, Valeria
Bruscaggin, Alessio
Zucca, Emanuele
Cavalli, Franco
Stuessi, Georg
Neri, Antonino
Ferrarini, Manlio
Rosenquist, Richard
Foa, Robin
Pospisilova, Sarka
Morabito, Fortunato
Montserrat, Emili
Gaidano, Gianluca
Wierda, William G.
Rossi, Davide
[J]. BLOOD, 2018, 132
[6] Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine
E Van Den Neste
V Robin
J Francart
A Hagemeijer
M Stul
P Vandenberghe
A Delannoy
A Sonet
V Deneys
S Costantini
A Ferrant
A Robert
L Michaux
[J]. Leukemia, 2007, 21 : 1715 - 1722
[7] Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine
Van Den Neste, E.
Robin, V.
Francart, J.
Hagemeijer, A.
Stul, M.
Vandenberghe, P.
Delannoy, A.
Sonet, A.
Deneys, V.
Costantini, S.
Ferrant, A.
Robert, A.
Michaux, L.
[J]. LEUKEMIA, 2007, 21 (08) : 1715 - 1722
[8] Cytogenetic abnormalities predict treatment-free interval and response to therapy in previously untreated chronic lymphocytic leukemia patients
Giertlova, M.
Hajikova, M.
Vaskova, J.
Kafkova, A.
Stecova, N.
Mirossay, L.
Karabinos, A.
Tothova, E.
Sarisskyr, M.
[J]. NEOPLASMA, 2011, 58 (01) : 82 - 88
[9] CIRCULATING HORMONES AND NUCLEAR HORMONE RECEPTOR EXPRESSION ARE ASSOCIATED WITH TREATMENT-FREE SURVIVAL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Allain, Eric
Venzl, Karin
Caron, Patrick
Turcotte, Veronique
Simonyan, David
Gruber, Michaela
Le, Trang
Levesque, Eric
Geuillemette, Chantal
Vanura, Katrina
[J]. DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S29 - S29
[10] LDH Levels Predict Progression-Free Survival in Treatment-NaIVe Patients with Trisomy 12 Chronic Lymphocytic Leukemia
Autore, Francesco
Strati, Paolo
Innocenti, Idanna
Corrente, Francesco
Trentin, Livio
Cortelezzi, Agostino
Coscia, Marta
Gozzetti, Alessandro
Gentile, Massimo
Morabito, Fortunato
D'Arena, Giovanni
Murru, Roberta
Vincelli, Donatella Iolanda
Reda, Gianluigi
Vitale, Candida
Ferrajoli, Alessandra
Laurenti, Luca
[J]. BLOOD, 2016, 128 (22)

← 1 2 3 4 5 →